Clinical Trial

First-in-Human Trial of DS1025a in Participants With Advanced Solid Tumors

Name: First-in-Human Trial of DS1025a in Participants With Advanced Solid Tumors — clinical trial record (NCT07681882)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This clinical trial is designed to assess the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and preliminary efficacy signals of DS1025a, given as a single agent to participants with advanced, metastatic, or unresectable solid tumors.

Protocol Amendment History 1 change

critical Recruitment opened 2026-08-11

Trial Details

NCT Number	NCT07681882
Lead Sponsor	Daiichi Sankyo
Conditions	Advanced Solid Tumor, Metastatic Solid Tumor, Unresectable Solid Tumor
Enrollment	45 participants
Start Date	2026-08-06
Primary Completion	2028-01-21 (estimated)
Study Completion	2029-01-21 (estimated)
Updated on ClinicalTrials.gov	2026-08-10